Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Postoperative Chemotherapy After Neoadjuvant Therapy and Pancreatectomy for Pancreatic Cancer: Balancing Patient Physiology and Disease Biology

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, et al. FOLFIRINOX or Gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med. 2018;379:2395–406.

    Article  CAS  Google Scholar 

  2. Kamarajah SK, White SA, Naffouje S, Salti GI, Dahdaleh F. Adjuvant chemotherapy associated with survival benefit following neoadjuvant chemotherapy and pancreatectomy for pancreatic ductal adenocarcinoma: a population-based cohort study. Ann Surg Oncol. 2021.

  3. Perri G, Prakash L, Qiao W, Varadhachary GR, Wolff R, Fogelman D, et al. Postoperative chemotherapy benefits patients who received preoperative therapy and pancreatectomy for pancreatic adenocarcinoma. Ann Surg. 2020;271:996–1002.

    Article  Google Scholar 

  4. Katz MHG, Ou FS, Herman JM, Ahmad SA, Wolpin B, Marsh R, et al. Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas. BMC Cancer. 2017;17:505.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Queen Elizabeth Hospital Birmingham, University Hospital Birmingham NHS Trust, Birmingham, UK

    Sivesh K. Kamarajah BMedSci, MBChB

  2. Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

    Sivesh K. Kamarajah BMedSci, MBChB

  3. Department of Surgical Oncology, Edward-Elmhurst Health, Naperville, IL, USA

    Fadi Dahdaleh MD

Authors
  1. Sivesh K. Kamarajah BMedSci, MBChB
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fadi Dahdaleh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fadi Dahdaleh MD.

Ethics declarations

Disclosure

The authors have no financial disclosures or conflicts of interest to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kamarajah, S.K., Dahdaleh, F. ASO Author Reflections: Postoperative Chemotherapy After Neoadjuvant Therapy and Pancreatectomy for Pancreatic Cancer: Balancing Patient Physiology and Disease Biology. Ann Surg Oncol 28, 6803–6804 (2021). https://doi.org/10.1245/s10434-021-09896-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-09896-x

Search

Navigation